Synthesis of osteotropic hydroxybisphosphonate derivatives of fluoroquinolone antibacterials

被引:53
|
作者
McPherson, James C., III [2 ]
Runner, Royce [2 ]
Buxton, Thomas B. [2 ]
Hartmann, John F. [3 ]
Farcasiu, Dan
Bereczki, Ilona [1 ]
Roth, Erzsebet [1 ]
Tollas, Szilvia [1 ]
Ostorhazi, Eszter [4 ]
Rozgonyi, Ferenc [4 ]
Herczegh, Pal [1 ]
机构
[1] Univ Debrecen, Dept Pharmaceut Chem, Med & Hlth Sci Ctr, H-4010 Debrecen, Hungary
[2] Eisenhower Army Med Ctr, Dept Clin Invest, Ft Gordon, GA USA
[3] ElizaNor Biopharmaceut Inc, Princeton Jct, NJ USA
[4] Semmelweis Univ, Dept Dermatol Venerol & Dermatooncol, Microbiol Lab, H-1085 Budapest, Hungary
关键词
Fluoroquinolone; Antibiotic; 1-Hydroxybisphosphonate; Osteotropic; Bone model; Adsorption; BONE RESORPTION; TISSUE CULTURE; BISPHOSPHONATES; PRODRUGS; OSTEOMYELITIS; DISSOLUTION; PREVENTION; DELIVERY; VITRO;
D O I
10.1016/j.ejmech.2011.10.049
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
1-Hydroxybisphosphonate derivatives of ciprofloxacin, gatifloxacin and moxifloxacin have been synthesized using Cu(I) catalyzed azide-alkyne 1,3-dipolar cycloaddition reaction. The 1,2,3-triazol linked hydroxybisphosphonate derivative of ciprofloxacin exhibited antibacterial activity comparable to the parent antibiotic and all fluoroquinolone-bisphosphonates displayed osteotropic properties in a bone model. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:615 / 618
页数:4
相关论文
共 50 条
  • [41] Synthesis, antibacterial evaluation and in silico study of DOTA-fluoroquinolone derivatives
    Weitian Li
    Ge Hong
    Lina Mao
    Zengping Xu
    Jiawen Wang
    Wenzhi Wang
    Tianjun Liu
    Medicinal Chemistry Research, 2022, 31 : 705 - 719
  • [42] Synthesis, antibacterial evaluation and in silico study of DOTA-fluoroquinolone derivatives
    Li, Weitian
    Hong, Ge
    Mao, Lina
    Xu, Zengping
    Wang, Jiawen
    Wang, Wenzhi
    Liu, Tianjun
    MEDICINAL CHEMISTRY RESEARCH, 2022, 31 (05) : 705 - 719
  • [43] Novel quinolone derivatives as potent antibacterials
    Lohray, BB
    Baskaran, S
    Rao, BS
    Mallesham, B
    Bharath, KSN
    Reddy, BY
    Venkateswarlu, S
    Sadhukhan, AK
    Kumar, MS
    Sarnaik, HM
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (05) : 525 - 528
  • [44] Relationship Between Physicochemical and Osteotropic Properties of Bisphosphonic Derivatives: Rational Design for Osteotropic Drug Delivery System (ODDS)
    Hideki Hirabayashi
    Taiji Sawamoto
    Jiro Fujisaki
    Yuji Tokunaga
    Sumihisa Kimura
    Takehisa Hata
    Pharmaceutical Research, 2001, 18 : 646 - 651
  • [45] Occurrence, fate and antibiotic resistance of fluoroquinolone antibacterials in hospital wastewaters in Hanoi, Vietnam
    Hong Anh Duong
    Ngoc Ha Pham
    Hoang Tung Nguyen
    Thi Thuong Hoang
    Hung Viet Pham
    Van Ca Pham
    Berg, Michael
    Giger, Walter
    Alder, Alfredo C.
    CHEMOSPHERE, 2008, 72 (06) : 968 - 973
  • [46] Third and Fourth Generation Fluoroquinolone Antibacterials: A Systematic Review of Safety and Toxicity Profiles
    Sousa, Joana
    Alves, Gilberto
    Fortuna, Ana
    Falcao, Amilcar
    CURRENT DRUG SAFETY, 2014, 9 (02) : 89 - 105
  • [47] Syntheses and biological evaluation of new fluoroquinolone antibacterials containing chiral oxiimino pyrrolidine
    Choi, DR
    Shin, JH
    Yang, J
    Yoon, SH
    Jung, YH
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (05) : 1273 - 1277
  • [48] Relationship between physicochemical and osteotropic properties of bisphosphonic derivatives: Rational design for Osteotropic Drug Delivery System (ODDS)
    Hirabayashi, H
    Sawamoto, T
    Fujisaki, J
    Tokunaga, Y
    Kimura, S
    Hata, T
    PHARMACEUTICAL RESEARCH, 2001, 18 (05) : 646 - 651
  • [49] Herbicidal activity of fluoroquinolone derivatives
    Wallace, Michael D.
    Debowski, Aleksandra W.
    Sukhoverkov, Kirill V.
    Mylne, Joshua S.
    Stubbs, Keith A.
    PLANT DIRECT, 2021, 5 (09)
  • [50] An Insight into Patents of Fluoroquinolone Derivatives
    Sharma, Prabodh Chander
    Piplani, Mona
    Rajak, Harish
    LETTERS IN DRUG DESIGN & DISCOVERY, 2015, 12 (10) : 844 - 855